相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。R-Loop Analysis by Dot-Blot
Prisila Ramirez et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2021)
Unlocking the potential of antibody-drug conjugates for cancer therapy
Joshua Z. Drago et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Novel one-shot fluorescent aptasensor for dengue fever diagnosis using NS1-induced structural change of G-quadruplex aptamer
Jihyun Mok et al.
SENSORS AND ACTUATORS B-CHEMICAL (2021)
G-quadruplex, Friend or Foe: The Role of the G-quartet in Anticancer Strategies
Josue Carvalho et al.
TRENDS IN MOLECULAR MEDICINE (2020)
Molecular Engineering-Based Aptamer-Drug Conjugates with Accurate Tunability of Drug Ratios for Drug Combination Targeted Cancer Therapy
Fang Zhou et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development
Tao Wang et al.
BIOTECHNOLOGY ADVANCES (2019)
Aptamer-based targeted therapy
Guizhi Zhu et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
DNA Topoisomerase I differentially modulates R-loops across the human genome
Stefano G. Manzo et al.
GENOME BIOLOGY (2018)
A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer
Fangfei Li et al.
NATURE COMMUNICATIONS (2017)
Nucleolin-targeted Extracellular Vesicles as a Versatile Platform for Biologics Delivery to Breast Cancer
Yayu Wang et al.
THERANOSTICS (2017)
Aptamer-nanoparticle complexes as powerful diagnostic and therapeutic tools
Hunho Jo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
Aptamer-Drug Conjugates
Guizhi Zhu et al.
BIOCONJUGATE CHEMISTRY (2015)
Cell Surface Nucleolin as a Target for Anti-Cancer Therapies
Marina Koutsioumpa et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2014)
Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy
Jiehua Zhou et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Initial Testing (Stage 1) of the Antibody-Maytansinoid Conjugate, IMGN901 (Lorvotuzumab Mertansine), by the Pediatric Preclinical Testing Program
Andrew C. Wood et al.
PEDIATRIC BLOOD & CANCER (2013)
Optimized End-Stacking Provides Specificity of N-Methyl Mesoporphyrin IX for Human Telomeric G-Quadruplex DNA
John M. Nicoludis et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Aptamer-Mediated Delivery of Splice-Switching Oligonucleotides to the Nuclei of Cancer Cells
Jonathan W. Kotula et al.
NUCLEIC ACID THERAPEUTICS (2012)
Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer
Teemu T. Junttila et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Aptamers as therapeutics
Anthony D. Keefe et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
Paula J. Bates et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
Screening for peptides binding on Phytophthora capsici extracts by phage display
Hye-Yeon Park et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2009)
The nucleolin targeting aptamer AS1411 destabilizes bcl-2 messenger RNA in human breast cancer cells
Sridharan Soundararajan et al.
CANCER RESEARCH (2008)
Quadruplex DNA: sequence, topology and structure
Sarah Burge et al.
NUCLEIC ACIDS RESEARCH (2006)
G-quartets 40 years later: From 5 '-GMP to molecular biology and supramolecular chemistry
JT Davis
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)
Mfold web server for nucleic acid folding and hybridization prediction
M Zuker
NUCLEIC ACIDS RESEARCH (2003)
Interaction of human nuclear topoisomerase I with guanosine quartet-forming and guanosine-rich single-stranded DNA and RNA oligonucleotides
C Marchand et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Synergistic interaction between topotecan and microtubule-interfering agents
HR Bahadori et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
Interaction of human DNA topoisomerase I with G-quartet structures
PB Arimondo et al.
NUCLEIC ACIDS RESEARCH (2000)